Twist Bioscience Shares Jump on Record Revenue, Raised Guidance and Path to Profitability
Twist Bioscience shares rose after record $118.4M Q3 revenue (+23% YoY), 14th sequential growth quarter, raised FY26 outlook, and path to EBITDA breakeven.
/ 2 items
